{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12372323",
  "DateCompleted": {
    "Year": "2002",
    "Month": "11",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "27"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0195-6701",
      "JournalIssue": {
        "Volume": "52",
        "Issue": "1",
        "PubDate": {
          "Year": "2002",
          "Month": "Sep"
        }
      },
      "Title": "The Journal of hospital infection",
      "ISOAbbreviation": "J Hosp Infect"
    },
    "ArticleTitle": "Importance of focus identification in the treatment of Staphylococcus aureus bacteraemia.",
    "Pagination": {
      "StartPage": "29",
      "EndPage": "36",
      "MedlinePgn": "29-36"
    },
    "Abstract": {
      "AbstractText": [
        "Staphylococcus aureus bacteraemia increases in frequency, and it is still a life-threatening disease. In recent years, some interesting studies such as the need for focus identification and the focus eradication have been performed. The aim of this review is to present an up-to-date assessment of the current challenges in the management of S. aureus bacteraemia in order to improve the outcome."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sector for Microbiology, Statens Serum Institut, Copenhagen, Denmark. allan.garlik@dadlnet.dk"
          }
        ],
        "LastName": "Jensen",
        "ForeName": "A G",
        "Initials": "AG"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Hosp Infect",
    "NlmUniqueID": "8007166",
    "ISSNLinking": "0195-6701"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "mortality",
        "physiopathology",
        "therapy"
      ],
      "DescriptorName": "Bacteremia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "diagnosis",
        "physiopathology",
        "therapy"
      ],
      "DescriptorName": "Community-Acquired Infections"
    },
    {
      "QualifierName": [
        "diagnosis",
        "physiopathology",
        "therapy"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "mortality",
        "physiopathology",
        "therapy"
      ],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Staphylococcus aureus"
    }
  ],
  "NumberOfReferences": "83"
}